Matinas BioPharma Holdings (FRA:6LJ0) Accumulated Depreciation : €-0.05 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Matinas BioPharma Holdings Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Matinas BioPharma Holdings's quarterly accumulated depreciation increased from Sep. 2024 (€-1.78 Mil) to Dec. 2024 (€-1.97 Mil) but then stayed the same from Dec. 2024 (€-1.97 Mil) to Mar. 2025 (€-0.05 Mil).

Matinas BioPharma Holdings's annual accumulated depreciation increased from Dec. 2022 (€-1.29 Mil) to Dec. 2023 (€-1.55 Mil) and increased from Dec. 2023 (€-1.55 Mil) to Dec. 2024 (€-1.97 Mil).

Matinas BioPharma Holdings Accumulated Depreciation Historical Data

The historical data trend for Matinas BioPharma Holdings's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Matinas BioPharma Holdings Accumulated Depreciation Chart

Matinas BioPharma Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-0.66

-0.92

-1.29

-1.55

-1.97

Matinas BioPharma Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated Depreciation	Get a 7-Day Free Trial															-1.65	-1.75	-1.78	-1.97	-0.05

Matinas BioPharma Holdings Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Matinas BioPharma Holdings Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Matinas BioPharma Holdings's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Matinas BioPharma Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matinas BioPharma Holdings Inc (FRA:6LJ0) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

MTNB:USA

Address

1545 Route 206 South, Suite 302, Bedminster, NJ, USA, 07921

Website

https://www.matinasbiopharma.com

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Matinas BioPharma Holdings Headlines

No Headlines